PharosBio
pharos.bio
Actively hiring
Drug Discovery
Drug Discovery AI
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
1-10
employees, estimated range
Momentum
0/100
no fresh signals
Tractionpublic signals, read monthly
Web presence
top 40%
of 133.2M domains by links, Common Crawl
Registers and programsofficial lists and records that name the company
| Legal entity | PharosBio ApS | its site |
Similar startupsby what they do, their industry and backers
Genesis Molecular AI is a drug discovery company headquartered in Burlingame, California, and founded in 2019. The company combines deep…
Axon is an interactive AI platform that accelerates drug discovery by amplifying the utility of cheminformatics, physics-based simulation…
Abzu® empowers scientists to bring drugs to market faster by accelerating their exploration and understanding. From disease understanding…
The only integrated full-stack AI platform for small molecule drug discovery.
Variational AI is a Canadian technology company founded in 2019 and based in Vancouver. It builds generative models that design small…
Inductive Bio builds machine learning models that predict the absorption, distribution, metabolism and toxicity properties of drug…
Overview
PharosBio is building an autonomous AI scientist—a platform and APIs that help biopharma and research teams reduce R&D risk by turning fragmented evidence into decisions across discovery and translation. The problem Despite billions spent on R&D, the research ecosystem runs on incomplete, siloed insight. Around 90% of drug candidates still fail in the clinic, wasting time and capital and delaying therapies for patients.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Copenhagen
Denmark
HQ
1-10 est. staff